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In Vivo Mobilization of Polymorphonuclear Leukocytes in Psoriasis: 
Relationship to Clinical Parameters and Serum Inhibitory Factors 
MAJA TIGALONOWA, M.D., WIESLAW GLINSKI, M.D., AND STEFANIA JABLONSKA, M .D. 
Department of Dermatology, Academy of Medicine, Warsaw, Poland 
Mean migration of polymorphonuclear leukocytes 
(PMNL) toward autologous and homologous control 
sera, evaluated by quantitative skin window chamber 
technique, was .only slightly reduced in 60 patients with 
psoriasis as compared to 27 normal controls (p < 0.1). A 
significant decrease in cell migration was found (1) in 
patients with actively spreading lesions, (2) in patients 
with extensive lesions involving more than 40-60% of 
the skin surface, (3) in the first 2 months of relapse, and 
(4) 5-6 months after onset of new lesions. However, 
PMNL migration was increased when psoriatic lesions 
lasted 3-4 months. Seventy-one percent of psoriatic sera 
exerted a suppressive effect on the psoriatic and normal 
PMNL migration. The inhibitors were found predomi-
nantly in patients with stationary and long-standing 
lesions. Some of the psoriatic sera had a stimulatory 
effect on the chemotaxis of psoriatic PMNL. These sera 
originated from those patients with active spreading 
lesions in the first 2 months of relaps_e. · 
These data indicate that neutrophil migration is ab-
normal in the course of psoriasis and that it could be 
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Abbreviations: 
HBSS: Hanks' balanced salt solution 
PMNL: polymorphonuclear leukocytes 
modified by different proportions of both inhibitors and 
stimulators of chemotaxis. 
Polymorphonuclear leukocytes (PMNL) seem to play an 
important role in the pathogenesis of psoriasis. They are a 
constant constitl,lent of inftltrates of early psoriatic papules 
[1,2). Their chemotaxis in vitro toward different attractants [3-
6], their adherence [7], oxidative system function [8], and the 
intracellular content of neutral proteinases [9] were found to be 
increased. 
In in vitro chemotaxis studies using the Boyden chamber 
method, inhibitors and stimulators of PMNL migration were 
detected in psoriatic serum [10-13]. Stimulatory activity was 
directed toward psoriatic neutrophils [12] and also toward 
normal cells [13]. The inhibitors of PMNL function were pre-
sent in patients with widespread [11] and long-standing [13] 
psoriatic lesions. 
Breathnach et al [14], using a quantitative skin window 
chamber technique, have found that in vivo migration of PMNL 
toward 50% autologous serum in patients with psoriatic lesions 
involving more than 25% of the skin surface was lower than in 
patients with minor skin involvement and in normals. In con-
trast, in cases of untreated psoriasis Dubertret et al [15] re-
ported on an increased penetration of cells within 8 h through 
skin window. More detailed studies on larger series of patients 
with an account of clinical parameters have not been reported. 
The purpose of our study was to analyze by the quantitative 
skin window chamber technique: (1) migration of PMNL as 
related to the activity of the disease, the duration of the relapse, 
and the extent of psoriatic lesions, and (2) the effect of normal 
and psoriatic sera on PMNL migration through the skin win-
dow. 
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MATERIALS AND METHODS 
Selection of Patients 
Studies were performed in 80 patients with psoriasis vulgaris and in 
49 healthy volunteers. The patients had not received systemic medi-
cation for at least 3 months prior to the experiment. Topical treatment 
with corticosteroids, salicylic acid, anth1·alin, and tar was withdrawn 2 
weeks prior to testing. The clinical state of the patients was evaluated 
according to the activity of the disease, as well as the extent and onset 
of the last relapse. Activity was determined by 2 observers and graded 
as: A2, mainly widely disseminated papules and pinpoint lesions; A1, 
peripherally spreading large psoriatic plaques, occasionally with small 
papules in the surrounding area; and AO, stationru·y skin lesions. The 
extent of cutaneous involvement was defined as: less than 10%, ll-20%, 
21-40%, 41-60%, and more than 60%. 
Quantitative Shin Window Chamber Technique 
A modification of the method described by Mass et al [16) was 
applied. Approximately 500 experiments were done, 3-6 on each pa-
tient. The volar surface of the forearm was moistened with water for 1 
h to facilitate tape stripping. The skin was treated with Betadine and 
70% ethyl alcohol. Stripping was performed over a template with 
prepared square holes (1 cm2 ), until capillary loops becan1e visible 
through the glistening surface of the skin. The test sites were next 
swabbed with saline to remove fragments of the epidermis. Sterile glass 
chambers of our own design were fastened with tissue glue over the 
test sites and filled with media to 2 cc total volume. After 8 h, fluid in 
the chambers was aspirated and suspended cells were counted in a 
hemocytometer. Fluid, after 8 h, was found to be sterile. Cell smears 
prepared from each test were stained by the May-Griinwald-Giemsa 
method and also stained for peroxidase activity. Differential cell counts 
of leukocytes migrating during the 8 h showed that more than 93% of 
the cells were PMNL, as reported previously [17]. 
Results were presented as the total number of leukocytes migrated 
per 1 cm2 skin window within 8 h in each chamber. The reproducibility 
of the technique was satisfactory. 
Chemoattractive Media 
A variety of media, including 50% autologous serum (psoriatic or 
normal), 50% pooled homologous serum from normal donors, 50% 
psoriatic homologous serum, and 0.5% casein (Sigma Chemical Corp., 
St. Louis, Missouri) in Hanks' balanced salt solution (HESS) were 
used. Sera were stored in portions at -40°C; before the experiment 
they were diluted with an equal volume ofHBSS. Some sera were heat-
inactivated. 
RESULTS 
Migration of PMNL Toward Various Media in Psoriatic 
Patients and Normal Volunteers 
In 60 patients with psoriasis, mean neutrophil mobilization 
through skin window by 50% autologous serum (5.03 X 106 
PMNL/cm 2 ) and by 50% normal homologous serum (4.91 X 106 
PMNL/cm2 ) was only slightly reduced in comparison with 
normal volunteers (6.06 and 5.72 X 106 PMNL/cm 2, respec-
tively). An approximately 2-fold lower migration of cells was 
found when casein was used instead of serum, both in psoriatics 
(2.45 X 106 PMNL/cm 2 ) and in normals (2.41 X 106 PMNL/ 
cm2 ). Only a few migrating PMNL were present in the medium 
alone (Table 1) . 
In patients with psoriasis, there was a direct correlation 
between neutrophil mobilization by casein and by 50% sera-
both autologous and normal. The higher the cell migration 
TABLE I. Migration of PMNL through shin window inpatients with 
p soriasis and in normal controls 
Number of PMNL x 10-• per I em' 
Fluid in chamber Psoriasis (60) Normals (27) t- test 
Mean SD Mean SD 
Medium 0.17 0.09 0.21 O.ll NS 
Autologous serum 5.03 3.39 6.06 3.09 NS 
Homologous serum 4.91 3.23 5.72 2.71 NS 
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FIG 1. Number of PMNL penetrating through the skin window as 
related to the onset of the last relapse (mean ± SEM). For the 
autologous serum (0- - - -0) , values were statistically different at <1 
month and >8 months vs. 2-4 months (p < 0.02) and vs. normal 
controls (p < 0.05); for the homologous serum (e---e) , >8 months 
vs. 2-4 months and/ or normal controls (p < 0.02); and for casein 
(o--0), 2-4 months vs. 1-2 months (p < 0.05). 
through the skin window to casein, the g1.·eater the migration to 
sera. 
Relationship of PMNL Chemotaxis to Duration, Extent, and 
Activity of Psoriatic Lesions 
The number of PMNL in chamber media in patients with 
P.soriasis was analyzed with respect to the duration of recent 
relapse (Fig 1). In the first 2 months after the appearance of 
psoria tic lesions, the migration of neutrophils to autologous and 
homologous sera was significantly lower in comparison with 
that of the control group. In contrast, an increased number of 
cells was found in patients with a relapse period of about 4 
months duration. However, if the relapse lasted longer than 5-
6 months, autologous and homologous sera induced much lower 
cell migration through the skin window to the chamber than in 
normals. 
Similar, although lower, peak increases of PMNL chemotaxis 
about 4 months after the onset of lesions was found in experi-
ments with casein (Fig 1). 
Patients with involvement of more than 60% of the total skin 
smface we1·e shown to have a 2-fold reduction of neutrophil 
migration toward the autologous serum (2.44 X 106 PMNL/ 
cm2 ) through the skin window as compared with normal con-
trols. Significantly reduced PMNL chemotaxis toward normal 
homologous serum was present also in the patients with moi·e 
than 40% of the skin involved. The remaining patients had cell 
numbers within the normal range (Table II). 
In active psoriasis (A2), migration of PMNL toward the 
homologous serum (5.62 X 106 PMNL/cm 2 ) was similar to that 
of normal PMNL attracted by the normal serum (5.72 X 106 
PMNL/cm 2 ) . Response to casein in this group did not differ 
from the migration in normal controls (2.18 and 2.41 X 106 
PMNL/cm 2, respectively). In contrast, chemotaxis of psoriatic 
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TABLE II. Number of PMNL migrating through slzin window as related to the extent of psoriatic lesions (n = 60) 
Number of PMNL x w-• per I cm2 (mean ± SD) 
Exten t of psoria tic skin lesions 
Fluid in chamber 
Autologous serum 




5.84 ± 2.88 
4.98 ± 3.40 
2.64 ± 1.76 
11-20% 21-40% 
(1 2) (20) 
5.55 ± 3.28 4.94 ± 3.57 
4.76 ± 2.60 6.13 ± 3.29 
2.01 ± 0.44 2.88 ± 2.09 
Normals 
41-60% > 60% (27) 
(12) (5) 
4.40 ± 3.94 2.44 ± 1.84" 6.06 ± 3.09 
2.98 ± 2.19" 1.92 ± 1.78" 5.72 ± 2.71 
1.70 ± 1.49 2.05 ± 0.80 2.41 ± 1.39 
" Statistical comparison (t-test), mean migration different from normal controls: p < 0.02. 
" Statistical comparison (t-test) , mean migration different from normal controls: p < 0.01. 
TABLE III. M igration of PMNL through sl<in window inpatients 
with psoriasis related to the activity of the disease (n = 60) 
Number of PMNL x w-•; per I cm2 (mean ± SD) 
Fluid in chamber Activity of psoriatic lesions Normals 
0 I 2 (27) 
(12) (30) (18) 
Au tologous serum 4.82 ± 2.25 5.50 ± 3.54 2.94 ± 2.90" 6.06 ± 3.09 
Normal homolo- 4.14 ± 3.15 5.01 ± 3.13 5.62 ± 3.89 5.72 ± 2.71 
gous serum 
Casein 1.72 ± 0.54 2.59 ± 1.89 2.18 ± 1.1 5 2.41 ± 1.39 
" Statistical difference A2 vs. normals, p < 0.02. 
TABLE IV. Inhibito1y effect of homologous psoriatic sera on 
psoriatic and normal PMNL migration through skin window 
Initial Number of PMNL X 10 6 per I em' 
PMNL che- Group (mean ± S O) mo taxisa 
(no. of cells (no. of cases) Normal ho- P soria ti c ho· 
per 1 cm2 ) Autologous mologous mologous' 
<6 X 10'; Psoriasis (29) 2.68 ± 1.29 3.74 ± 2.63 3.83 ± 3.05 (55) 
Normals (12) 3.04 ± 1.91 3.31 ± 2.32 3.47 ± 2.37 (28) 
>6 X !Or. Psoriasis (21) 8.71 ± 1.94 7.56 ± 3.17 5.55 ± 2.76 (4 5)' 
Normals (16) 8.43 ± 1.78 6.77 ± 2.28 4.74 ± 2.30 (38)" 
" Psoriatic sera were tested in the subjects wit h high and low initial PMNL 
migration. · 
• In parentheses, number of sera tested. 
,. Sta tis tical significance (I- test) : psoriatic vs. a utologous serum, p < 0.001; 
psoriatic vs. normal homologous serum, p < 0.002. 
"Statistical significance (l-test): psoriatic vs. autologous serum, p < 0.001 ; 
psoriatic vs. normal homologous serum, p < 0.001. 
neutrophils toward autologous serum (2.94 X 106 PMNL/cm") 
was significantly decreased (Table III) . 
In patients with stationary lesions (AO), there was a reduc-
tion in psoriatic PMNL counts, both in autologous (4.82 x 106 
PMNL/cm2 ) and normal homologous (4.14 X 106 PMNL/ cm2 ) 
sera as well as in casein (1.72 X 106 PMNL/cm2 ). 
Effect of Homologous Psoriatic Sera on Psoriatic PMNL 
Migration 
The PMNL chemotaxis through skin window toward 100 
homologo.us psoriatic sera was tested in 50 patients with pso-
riasis and 28 normal volunteers. The results were compared 
with the PMNL migration toward autologous serum and normal 
homologous serum on each individual studied (Table IV). 
Because of the wide range of results, patients were divided 
into 2 groups on the basis of an initial PMNL ·migration to 
autologous serum-lower than 6 X 106 cells per 1 cm2 and 
higher than 6 X 106 cells per 1 cm2• The number of PMNL was 
significantly reduced in patients with psoriasis in the presence 
of homologous psoriatic sera (5.55 X 106 PMNL/cm2 ) in com-
parison with the migration to autologous serum (8.71 X 106 
PMNL/cm2 ) as well as to normal serum (7.56 X 106 PMNL/ 
cm2 ), if the subjects tested revealed a high initial PMNL 
chemotaxis. When the initial PMNL migration to autologous 
serum did not exceed 6 X 106 cells per 1 cm2, the migratory cell 
counts were not significantly different in all sera tested: autol-
ogous, normal homologous, and psoriatic homologous. 
TABLE V. Effect of homologous psoriatic serum on PMNL 
chemotaxis in patients with psoriasis as related to disease activity 
and extent of p soriatic serum donors 
Disease parame· 
ters in donors of 
pso riatic homolo-
gous serum 




Duration of disease 
<2 months 
2-4 mon ths 









Number of psoria tic PMNL 
x 10-" per 1 em' (mean ± 
S D) " 
Autologous 
serum 
7.36 ± 3.11 
8.73 ± 1.89 
8.31 ± 2.43 
7.67 ± 3.01 
8.64 ± 1.87 




7.73 ± 3.67 
6.02 ± 2.95'. 
3.94 ± 1.48'' 
7.26 ± 3.22 
5.95 ± 2.72" 
4.59 ± 1.22'. 
P ercent of pa tients 









" P soria tic se ra were tested in psoria t ics with high ini tial PMNL migration. 
" Above autologous serum-induced migra tion. 
' Sta tist ical comparison (t-test) : psoriatic vs. autologous serum, p < 0.001. 
"Statistical comparison (t-test): psoriatic vs. autologous serum, p < 0.005. 
Psoriatic sera induced much lower migration (4.74 X 106 
PMNL/cm2 ) in normal controls than either autologous (8.43 
X 106 PMNL/cm2 ) or normal homologous sera (6.77 X 106 
PMNL/cm2). 
This psoriatic serum-dependent decrease in the migration of 
psoriatic PMNL of unchanged initial motility was analyzed 
with respect to clinical parameters of psoriatic serum donors 
(Table V). The reduction in cell count induced by psoriatic sera 
as compared to autologous serum-induced chemotaxis was 
found when the sera were obtained from patients with station-
ary (A0-3.94 X 106 PMNL/cm2 ) and peripherally spreading 
(A1-6.02 x 106 PMNL/cm2 ) lesions, as well as in patients with 
psoriatic lesions of more than 2 months duration (5.95 X 106 
PMNL/cm2 ). 
Numerous sera of patients with actively spreading lesions 
(A2-57%) and patients with a recent relapse not exceeding 2 
months (53%) stimulated the PMNL migration in comparison 
with the initial migration due to autologous serum. However, 
the mean PMNL counts were within normal range in these 
patients (Table V) . 
There was no relationship between the decrease in the PMNL 
migration in the presence of psoriatic sera and the extent of 
psoriatic lesions of serum donors. 
When psoriatic sera were tested in normal subjects by the 
skin window technique, the reduction of PMNL chemotaxis 
was present in all subgoups of patients, irrespective of the 
activity of disease and/or extent and duration of recent relapse 
of psoriatic lesions (data not shown). 
DISCUSSION 
No significant difference was found between patients with 
psoriasis and the normal population in in vivo PMNL migration 
toward autologous and normal homologous serum. This is in 
agreement with the data of Breathnach et al [14], who found 
the mean PMNL chemotaxis to be normal in 50 psoriatics using 
the same quantitative skin window chamber technique. 
However, there was a markedly decreased mobilization of 
PMNL in 64% of patients, while 31% of cases had increased 
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mobilization. These disparate reactions occurred during recent 
relapse of psoriatic lesions. The PMNL migration was dimin-
ished in the first 2 months of relapse, elevated at 2.5- 4 months, 
and finally markedly depressed after 4 months. It would thus 
appear that selection of patients is a possible explanation for 
the increased PMNL migration through skin window reported 
in 9 psoriatic patients ·by Dubertret et al [15). 
The time parameter was also found to be important for the 
other correlations observed: the PMNL migration vs. the extent 
as well as the activity of psoriatic lesions. A majority of the 
patients with long-lasting skin lesions and low PMNL migration 
usually had more than 40-60% of the skin involved and an 
inactive disease (AO) . The patients with low PMNL migration, 
in whom the relapse period did not exceed 2 months, were 
found to have predominantly actively spreading lesions (A2). 
The decreased mobilization of psoriatic PMNL toward serum 
in psoriasis could be dependent upon: (1) in vivo depression of 
random PMNL motility; (2) increased content of serum inhib-
itors of chemotaxis in psoriatic serum; (3) lowered chemoat-
tractive activity of psoriatic serum; (4) excessive stimulation of 
circulating PMNL by one chemoattractant in vivo, which made 
the cells unresponsive to the other stimuli such as fresh human 
serum; (5) increased activity of tissue inhibitors of PMNL, etc. 
Random PMNL motility seemed to be unchanged in the 
patients with active psoriasis (A2) and in those with a relapse 
lasting less than 2 months as determined by the response of 
PMNL to normal homologous serum and/or casein. However, 
either the reduced activity of chemoattractants in psoriatic sera 
or the increased amount of inhibitors of chemotaxis could be 
responsible for migration of PMNL toward psoriatic serum to 
be less than towru·d normal serum in the patients with the most 
active lesions (A2). A depletion of some chemotactic compo-
nents of complement might be suggested on the basis of the 
data of Goldberg et al [17], who found that about 90% of 
chemotactic properties of human sera is dependent on the C5a 
activity. 
The elevated chemotaxis of PMNL between 2 and 4 months 
of the 1·elapse seemed to be due to the neutrophil hyperreactiv-
ity to chemotactic stimuli, as described previously [6,10-12). 
Generation of prostaglandins such as leukotriene B4 [18], and 
neutral proteinase-produced chemotactic factor [19] could be 
responsible for the stimulation of PMNL in some periods of 
disease as well as for the accumulation of PMNL in the psoriatic 
epidermis. 
In long-lasting psoriasis of about 6 months duration, the 
PMNL migration was lowered irrespective of the serum used in 
the chamber. This may be a result of in vivo decreased activity 
of cells at least in part related to inhibitors in psoriatic sera. 
Those inhibitors could be identical to the inhibitory factor 
associated with widespread psoriatic lesions, which was dem-
onstrated by the in vitro Boyden chamber method [11,13). The 
inhibition of PMNL migration might be related also to the 
increased serum IgA, which was found to suppress in vitro 
chemotaxis [13]. 
The presence of inhibitors of chemotaxis in the psoriatic sera 
was documented in acute plaque (A1) and in stationary (AO) 
psoriasis as well as in patients in whom the relapse lasted more 
than 2 months. The inhibitory factors of psoriatic sera could 
depress the PMNL migration only in the patients with psoriasis 
and/or normal controls who had normal initial migration of 
PMNL toward autologous or normal serum. 
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Our data also give some evidence for the presence of stimu-
latory factors in the psoriatic sera of patients with guttate 
psoriasis (A2) whose psoriatic lesions do not exceed 2 months 
duration. These factors were directed only to psoriatic PMNL, 
not to normal cells (data not shown). The activators of che-
motaxis were previously described in psoriasis by Kawohl et al 
[12] which were active toward psoriatic [12] or normal [13] 
PMNL. 
The mechanism of the decreased or increased PMNL migra-
tion in different forms and periods of psoriasis and the relation-
ship of PMNL migration to cell activation and serum factors 
remain to be elucidated. 
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